Cell Impact AB (publ) reported consolidated earnings results for the first ended March 31, 2021. For the quarter, on consolidated basis, the company reported net sales of SEK 12.1 million against SEK 7.1 million a year ago. Operating loss was SEK 14.4 million against SEK 11.5 million a year ago. Loss per share, attributable to the shareholders of the parent company was SEK 0.25 against SEK 0.25 a year ago. Loss attributable to the shareholders of the Parent Company was SEK 14.7 million against SEK 11.5 million a year ago.